EUROGIN homepage       Monday, September 25, 2017
 

Sponsors/Exhibitors

 

The EUROGIN organizing committee would like to thank the following companies for their support of the congress:

Platinum Sponsors


Gold Sponsors


Silver Sponsors


Bronze Sponsors


Exhibitors

MSD
Today's MSD is a global healthcare leader working to help the world be well. MSD is known as Merck in the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. MSD. Be well.

Address:
One Merck Drive
Whitehouse Station, NJ 08889-0100
USA

Phone: 908 423 1000
Website: For more information, visit http://www.msd.com
About QIAGEN
QIAGEN is the leading global provider of sample and assay technologies. The company offers one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as a "gold standard" in testing for high-risk types of human papillomavirus (HPV), as well as solutions for infectious disease testing and companion diagnostics. Further information about QIAGEN can be found at http://www.qiagen.com, more information about the HPV Test at http://www.thehpvtest.com.
Company Name: Sanofi Pasteur MSD
Company Address:8 rue Jonas Salk, 69367 Lyon, France
Website: www.spmsd.com

100 Word Company Profile

Building upon the legacy of pioneers like Louis Pasteur we want to help protect people against infectious diseases so that they can live longer, feel better and achieve more. We are dedicated exclusively to vaccines because we believe prevention is better than cure and immunisation is the best prevention.

Our 45 vaccines help protect people from 20 infectious diseases, including cervical cancer, liver cancer, tuberculosis, poliomyelitis, rabies, measles, yellow fever, shingles and influenza. Our vaccines help protect everyone – from infancy to old age.

Sanofi Pasteur MSD is a joint venture between sanofi pasteur - the vaccine division of sanofi-aventis - and Merck & Co. Inc.. We develop, license, manufacture and distribute vaccines in Western Europe. We lead the vaccine industry in Western Europe with an estimated 37% of the vaccine market in 2008.

Together with sanofi Pasteur and Merck we are working to make vaccines available to more people in the developing world, in alliance with organisations such as the World Health Organisation (WHO) and the Global Alliance for Vaccines and Immunisation (GAVI).

Gen-Probe’s APTIMA® HPV Assay targets mRNA expression of E6/E7 genes that are known to contribute to cancer progression.

Studies show that the APTIMA HPV Assay provides assurance of high sensitivity for detecting cervical pre-cancers and increased specificity for cervical disease; thus reducing false positive results, avoiding unnecessary medical procedures and unnecessary costs.

Gen-Probe is a global leader in infectious disease testing, blood screening, oncology and transplant diagnostics, providing molecular diagnostic solutions for women's health, including CT/GC, Trichomonas vaginalis and HPV.    For more information go to www.gen-probe.com

HOLOGIC
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. With the introduction of the Cervista™ HPV HR (high risk) test, Hologic now provides a complete cervical cancer screening portfolio with the ThinPrep® Pap test, a variety of advanced ThinPrep Processors, and the ThinPrep Imaging System. For additional information, please contact:

HOLOGIC UK Ltd
European Headquarters
Unit 2, Link 10
Napier Way
Crawley, West Sussex
RH10 9RA, United Kingdom
Tel: +44 1293 522 080
Fax: +44 1293 528 010
Roche Molecular Diagnostics is committed to developing innovative diagnostic products that provide actionable information in order to drive better health care decisions. By delivering a diagnostic test that identifies high risk HPV types and specific genotyping for HPV type 16 and 18, physicians can identify women most at risk for developing cervical cancer and reduce unnecessary procedures.

Roche Molecular Diagnostics, the world's leading molecular diagnostics company, develops and commercializes highly sensitive diagnostic and blood screening tests based on the company's Nobel-prizing winning PCR and now industry-standard real-time PCR technologies.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.
Women´s Health has been gaining a lot of importance in the last decade resulting in introduction of new preventive and diagnostic methods particular for cervical, ovarian and breast cancer. Please visit our booth for more information.

Company Name: Abbott GmbH & Co.KG
Company Address including Street:
Abbott Molecular
Max-Planck-Ring 2
City, Zip Code: 65205 Wiesbaden
Country: Germany
Website: www.abbottmolecular.com

BD (Becton, Dickinson and Company)
1 Becton Drive
Franklin Lakes, NJ 7417
USA
Website: www.bd.com

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

BD Diagnostics, one of the Company's three worldwide business segments, focuses on Women’s Health and Cancer by leveraging technologies and expertise across the Company to enhance disease detection and patient management. For clinicians who are passionate about women’s healthcare, BD Diagnostics is the diagnostic innovator, enabling confident treatment decisions driven by a uniquely relevant set of tests providing more definitive results.

For more information, please visit our booth!

IncellDx, Inc. is a molecular diagnostics company dedicated to the detection and monitoring of life threatening viral diseases in the areas of cervical cancer, HIV/AIDS, hepatitis, and organ transplant rejection.

IncellDx, Inc. is committed to bringing personalized medicine to infectious disease testing through innovative molecular diagnostic products.

Our technology combines Simultaneous Ultrasensitive Signal-amplified Hybridization In Situ (SUSHI) with a novel, cell-based instrument capable of quantifying molecular biomarkers inside intact cells. This allows protein and gene expression to be measured by distinct cell type which aids both diagnosis and disease localization. The technology is ultra-fast, inexpensive, highly reproducible, and able to perform complex molecular testing without DNA extraction or amplification.

www.incelldx.com
1700 El Camino Real Menlo Park, CA 94027
Phone: +650.777.7630
Greiner Bio-One, based in Frickenhausen (Germany), is an internationally leading technology partner for academia and research institutes as well as the diagnostic, pharmaceutical and biotechnology industries. The company is specialised in the development of innovative molecular biology analysis methods, including biochips or DNA microarrays. The PapilloCheck® Test Kit is based upon this technique and is intended to be used for the qualitative detection and differentiation of 24 types of human papillomaviruses (HPV) in DNA preparations from human cervical smears.

Greiner Bio-One GmbH
Maybachstraße 2, 72636 Frickenhausen, Germany
Phone: (+49) 70 22 948-0
Fax: (+49) 70 22 948-514
E-mail: info @de.gbo.com
www.gbo.com/bioscience